NASDAQ:HYPR

Hyperfine - HYPR Stock Forecast, Price & News

$1.25

-0.02 (-1.58%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.23
▼
$1.30
50-Day Range: $0.85
▼
$1.88
52-Week Range: $0.68
▼
$4.10

Volume: 90,515 shs
Average Volume: 1.48 million shs
Market Capitalization: $87.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.97

Institutional Ownership

Hyperfine MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 218.6% Upside
$3.97 Price Target
Short Interest: Bearish
5.20% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.81
Based on 19 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars

Medical Sector

686th out of 995 stocks

Electromedical Equipment Industry

14th out of 24 stocks

3.3

Analyst's Opinion

Consensus Rating
Hyperfine has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.97, Hyperfine has a forecasted upside of 218.6% from its current price of $1.25.
Amount of Analyst Coverage
Hyperfine has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
5.20% of the float of Hyperfine has been sold short.
Short Interest Ratio / Days to Cover
Hyperfine has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
Hyperfine does not currently pay a dividend.
Dividend Growth
Hyperfine does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HYPR.

3.2

News and Social Media Coverage

News Sentiment
Hyperfine has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 19 news articles for Hyperfine this week, compared to 1 article on an average week.
Search Interest
Only 5 people have searched for HYPR on MarketBeat in the last 30 days. This is a decrease of -64% compared to the previous 30 days.
MarketBeat Follows
6 people have added Hyperfine to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hyperfine insiders have not sold or bought any company stock.
Percentage Held by Insiders
26.11% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 27.65% of the stock of Hyperfine is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Hyperfine is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hyperfine is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Hyperfine has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products. The company's products include Swoop Portable MR imaging system, which offers neuroimaging at the point of care, as well as informs the timely diagnosis and treatment of acute conditions in a wide range of clinical settings. Hyperfine, Inc. was incorporated in 2014 and is based in Guilford, Connecticut.

Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Stock News Headlines

March 26, 2023 | americanbankingnews.com

Brokers Offer Predictions for Hyperfine, Inc.'s FY2023 Earnings (NASDAQ:HYPR)

March 23, 2023 | americanbankingnews.com

Hyperfine, Inc. (NASDAQ:HYPR) to Post Q1 2023 Earnings of ($0.16) Per Share, B. Riley Forecasts

March 27, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

March 23, 2023 | americanbankingnews.com

Hyperfine (NASDAQ:HYPR) Price Target Cut to $2.50 by Analysts at B. Riley

March 22, 2023 | finance.yahoo.com

Hyperfine, Inc. (HYPR) Interactive Stock Chart - Yahoo Finance

March 22, 2023 | americanbankingnews.com

Guided Therapeutics (OTCMKTS:GTHP) versus Hyperfine (NASDAQ:HYPR) Head-To-Head Contrast

March 22, 2023 | markets.businessinsider.com

Hyperfine (HYPR) Gets a Buy from B.Riley Financial

March 21, 2023 | finance.yahoo.com

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

March 27, 2023 | Weiss Ratings (Ad)

Banking Nightmare

During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …

March 20, 2023 | msn.com

Hyperfine's Earnings: A Preview

March 19, 2023 | americanbankingnews.com

Hyperfine (HYPR) to Release Quarterly Earnings on Tuesday

March 6, 2023 | finance.yahoo.com

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

February 28, 2023 | finance.yahoo.com

Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging

February 21, 2023 | finance.yahoo.com

Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations

February 14, 2023 | marketwatch.com

Hyperfine Gets FDA Clearance for Updated Swoop Brain-Imaging Software

February 8, 2023 | finance.yahoo.com

Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer

January 31, 2023 | marketwatch.com

Hyperfine Up 34% on Heavy Volume After Receiving Patent

December 1, 2022 | benzinga.com

187K Reasons To Be Bullish On Hyperfine Stock

November 22, 2022 | finance.yahoo.com

Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference

November 12, 2022 | seekingalpha.com

Hyperfine, Inc. (HYPR) Q3 2022 Earnings Call Transcript

November 11, 2022 | finanznachrichten.de

Hyperfine, Inc.: Hyperfine Reports Third Quarter 2022 Financial Results

November 10, 2022 | finance.yahoo.com

Hyperfine Reports Third Quarter 2022 Financial Results

October 27, 2022 | finance.yahoo.com

Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022

October 6, 2022 | finance.yahoo.com

Hyperfine Names Maria Sainz President and Chief Executive Officer

September 25, 2022 | ca.finance.yahoo.com

The past year for Hyperfine (NASDAQ:HYPR) investors has not been profitable

August 24, 2022 | finance.yahoo.com

Hyperfine to Participate in Upcoming Investor Conferences

August 18, 2022 | nasdaq.com

Shareholders in Hyperfine (NASDAQ:HYPR) have lost 85%, as stock drops 16% this past week

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Company Calendar

Today: 3/27/2023
Next Earnings (Estimated): 5/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HYPR
CUSIP: N/A
CIK: 1833769
Web: hyperfine.io
Phone: 866-796-6767
Fax: N/A
Employees: 186
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.97
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $2.40
Forecasted Upside/Downside: +218.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-64,850,000.00
Net Margins: -1,073.73%
Pretax Margin: -1,073.73%
Return on Equity: -50.83%
Return on Assets: -46.98%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 14.62
Quick Ratio: 11.21

Sales & Book Value

Annual Sales: $6.81 million
Price / Sales: 12.90
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.65 per share
Price / Book: 0.47

Miscellaneous

Outstanding Shares: 70,580,000
Free Float: 52,149,000
Market Cap: $87.87 million
Optionable: Not Optionable
Beta: 0.32

Key Executives

Mr. R. Scott Huennekens CPA (Age 58)
M.B.A., Exec. Chairman
Comp: $83.04k

Ms. Maria Sainz (Age 56)
CEO, Pres & Director
Comp: $1.78k

Dr. Jonathan M. Rothberg Ph.D. (Age 58)
Founder & Vice Chairman
Comp: $1.37k

Mr. Mark A. Hughes (Age 59)
VP of Hardware Engineering & Operations
Comp: $366.67k

Dr. Khan M. Siddiqui M.D. (Age 49)
Chief Medical Officer & Chief Strategy Officer
Comp: $475.25k

Mr. Alok Gupta (Age 56)
Chief Financial Officer

Ms. Kyla Pavlina J.D.
Chief People Officer

Mr. Scott A. White (Age 48)
Chief Commercial Officer

Mr. Tom Teisseyre
Chief Product Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HYPR Stock - Frequently Asked Questions

Should I buy or sell Hyperfine stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hyperfine in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HYPR shares.
View HYPR analyst ratings or view top-rated stocks.
What is Hyperfine's stock price forecast for 2023?: 3 brokerages have issued 1-year target prices for Hyperfine's shares. Their HYPR share price forecasts range from $2.40 to $7.00. On average, they expect the company's share price to reach $3.97 in the next year. This suggests a possible upside of 218.6% from the stock's current price.
View analysts price targets for HYPR or view top-rated stocks among Wall Street analysts.
How have HYPR shares performed in 2023?: Hyperfine's stock was trading at $0.84 at the start of the year. Since then, HYPR stock has increased by 48.2% and is now trading at $1.2450.
View the best growth stocks for 2023 here.
When is Hyperfine's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our HYPR earnings forecast.
What guidance has Hyperfine issued on next quarter's earnings?: Hyperfine issued an update on its FY 2023 earnings guidance on Wednesday, March, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $10.00 million-$14.00 million, compared to the consensus revenue estimate of $14.65 million.
What is Hyperfine's stock symbol?: Hyperfine trades on the NASDAQ under the ticker symbol "HYPR."

Who are Hyperfine's major shareholders?: Hyperfine's stock is owned by many different institutional and retail investors. Top institutional investors include HealthCor Management L.P. (5.50%), Security Benefit Life Insurance Co. KS (3.49%), Wells Fargo & Company MN (0.54%), Jefferies Financial Group Inc. (0.43%), Caz Investments LP (0.07%) and Susquehanna International Group LLP (0.04%). Insiders that own company stock include Alok Gupta, Hc Sponsor Llc, Jonathan M Rothberg, Khan Siddiqui, Maria Sainz and Neela Paykel.
View institutional ownership trends.
How do I buy shares of Hyperfine?: Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Hyperfine's stock price today?: One share of HYPR stock can currently be purchased for approximately $1.25.
How much money does Hyperfine make?: Hyperfine (NASDAQ:HYPR) has a market capitalization of $87.87 million and generates $6.81 million in revenue each year. The company earns $-64,850,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis.
How many employees does Hyperfine have?: The company employs 186 workers across the globe.
How can I contact Hyperfine?: Hyperfine's mailing address is 55 HUDSON YARDS 28TH FLOOR, NEW YORK NY, 10001. The official website for the company is hyperfine.io. The company can be reached via phone at 866-796-6767 or via email at investors@hyperfine.io.

This page (NASDAQ:HYPR) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hyperfine - HYPR Stock Forecast, Price & News

Hyperfine MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Hyperfine (NASDAQ:HYPR) Stock

HYPR Stock News Headlines

HYPR Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

HYPR Stock - Frequently Asked Questions

Overall MarketRank^™